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Dorsal dermis and epaxial muscle have been shown to arise from the central dermomyotome in the chick. En1 is a homeobox transcription
factor gene expressed in the central dermomyotome. We show by genetic fate mapping in the mouse that En1-expressing cells of the central
dermomyotome give rise to dorsal dermis and epaxial muscle and, unexpectedly, to interscapular brown fat. Thus, the En1-expressing central
dermomyotome normally gives rise to three distinct fates in mice. Wnt signals are important in early stages of dermomyotome development, but
the signal that acts to specify the dermal fate has not been identified. Using a reporter transgene for Wnt signal transduction, we show that the En1-
expressing cells directly underneath the surface ectoderm transduce Wnt signals. When the essential Wnt transducer β-catenin is mutated in En1
cells, it results in the loss of Dermo1-expressing dorsal dermal progenitors and dermis. Conversely, when β-catenin was activated in En1 cells, it
induces Dermo1 expression in all cells of the En1 domain and disrupts muscle gene expression. Our results indicate that the mouse central
dermomyotome gives rise to dermis, muscle, and brown fat, and that Wnt signalling normally instructs cells to select the dorsal dermal fate.
© 2006 Elsevier Inc. All rights reserved.Keywords: Dermomyotome; Skin; Cell fate; Dermis; Wnt; Brown fatIntroduction
The somites give rise to axial skeleton, striated muscle, and
dorsal dermis (Christ et al., 2004; Gossler and Hrabe de
Angelis, 1998; Hirsinger et al., 2000; Scaal and Christ, 2004).
Each somite displays restricted domains of gene expression and
these are thought to represent cell populations that will give rise
to the various tissue derivatives. The dermal derivative has been⁎ Corresponding authors.
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doi:10.1016/j.ydbio.2006.04.449the least explored with respect to where the dermal progenitors
come from and the identity of signals that instruct the cells of
the dermomyotome to adopt a dermal fate (Scaal and Christ,
2004).
Somites segment from the anterior end of the presomitic
mesoderm and form epithelial units (Pourquie, 2001). The
ventromedial portion of the somites become mesenchymal
again to form the sclerotome and the remainder of the somite
persists as an epithelial dermomyotome (Christ et al., 2004;
Gossler and Hrabe de Angelis, 1998; Hirsinger et al., 2000;
Scaal and Christ, 2004). Later, the central portion of the somite
undergoes an epithelial to mesenchymal transition (Scaal and
Christ, 2004). Historically, the dermis was assumed to derive
from this region of the dermomyotome, and it was termed the
dermatome (Scaal and Christ, 2004).
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tome” also contributes to fetal and postnatal epaxial skeletal
muscle and to adult muscle satellite cells in both chick and
mouse (Ben-Yair and Kalcheim, 2005; Gros et al., 2005;
Kassar-Duchossoy et al., 2005; Relaix et al., 2005). Thus, it has
been proposed that the dermatome instead be called the central
dermomyotome (Scaal and Christ, 2004). How the dermal and
muscle fates are selected from the broader dermomyotome
domain is not known. That the somite gives rise to the dorsal
dermis of the trunk was established by orthotopic transplanta-
tion of quail presomitic mesoderm into chick hosts (Mauger,
1972; Nowicki et al., 2003). Similar experiments showed that
the flank and belly dermis of the trunk comes from lateral plate
mesoderm (Mauger, 1972). However, which parts of the
presomitic mesoderm, somite, and dermomyotome give rise to
the dorsal dermis has not been resolved (Scaal and Christ,
2004).
In one map of somite-derived dermis, the cells which form
dermis are present first in the medial presomitic mesoderm and
then later in the medial portion of epithelial somites (Cheng et
al., 2004; Ordahl and Le Douarin, 1992). The dorsomedial lip
(DML) of the dermomyotome generates cells that move further
laterally within the plane of the dermomyotome (Cheng et al.,
2004; Ordahl et al., 2001), perhaps giving rise to much of the
dermomyotome (Ordahl et al., 2001). The DML-derived cells
translocate into a domain of cells that express the homeobox
transcription factor gene En1 and begin to express En1 (Cheng
et al., 2004). Dorsal dermis is thought to derive from cells which
expressed En1 (Cheng et al., 2004).
A second map also places somite-derived dermal progenitors
in the medial presomitic mesoderm (Olivera-Martinez et al.,
2000). Once the dermomyotome has formed, the DML gives
rise to mesenchymal cells that migrate early to form the dermis
over the neural tube (Houzelstein et al., 2000; Olivera-Martinez
et al., 2002). The majority of the dorsal somite-derived dermis
arises from dermomyotomal cells that express En1 (Olivera-
Martinez et al., 2002).
Finally, one group has found that both medial and lateral
halves of the epithelial somites give rise to dermis (Ben-Yair et
al., 2003). According to the results from this group, the
dermomyotome does not grow from the DML and the
dermomyotome exclusive of its medial and lateral lips gives
rise to dermis (Ben-Yair et al., 2003). In this map, the dermis
over the neural tube arises later in development, from the central
dermomyotome (Ben-Yair et al., 2003).
The signals that are required for the formation of dermis from
the central dermomyotome are not known. There are several
results which suggest that members of the Wnt family are
excellent candidates for the signal that promotes the develop-
ment of dermis from the central dermomyotome. Wnts are
expressed in the surface ectoderm (Parr et al., 1993; Rodriguez-
Niedenfuhr et al., 2003; Schubert et al., 2002), and blocking
Wnts with Dkk in the chick results in a thinner dermis (Chang et
al., 2004) and loss of feather follicles (our unpublished studies).
Wnts are important in several earlier steps of somite and
dermomyotomal development, including segmentation, somite
epithelialization, dermomyotome proliferation, and expressionof Pax3, Pax7, and En1 in the dermomyotome (Aulehla et al.,
2003; Linker et al., 2005; Nakaya et al., 2004; Schmidt et al.,
2004; Galli et al., 2004; Capdevila et al., 1998; Fan et al., 1997;
Fan and Tessier-Lavigne, 1994; Schmidt et al., 2004). The
expression of En1 in the central dermomyotome requires Wnts
from the dorsal neural tube in the mouse (Ikeya and Takada,
1998), and from the dorsal neural tube and the surface ectoderm
in the chick (Cheng et al., 2004; Olivera-Martinez et al., 2001).
After the formation of dermis, signals from the dorsal neural
tube are necessary for its survival (Olivera-Martinez et al.,
2001). Wnt1 can substitute for the dorsal neural tube signal, but
it is not clear if Wnt1 acts directly or indirectly (Olivera-
Martinez et al., 2001). Much later in development, Wnt signal
transduction in the epidermis is necessary for the development
of hair and feathers (Chang et al., 2004; Huelsken et al., 2001;
Lo Celso et al., 2004; Silva-Vargas et al., 2005), and it has been
suggested that the dermal condensations participating in early
stages of hair follicle development might require Wnt signal
transduction (DasGupta and Fuchs, 1999; Kishimoto et al.,
2000; Ridanpaa et al., 2001). At the intermediate stage when the
central dermomyotome generates dermal progenitors, it has
been hypothesized, but not tested, that Wnt signaling is
necessary for dermal specification (Scaal and Christ, 2004).
Here we determined the fate of the En1-expressing cells of
the central dermomyotome in the mouse and found that the
central dermomyotome tissue is tripotent in that it gives rise to
interscapular brown fat bundles in addition to dermis and
muscle. Our results also clarify the fate map of the
dermomyotome relative to the dorsal dermis in the mouse.
Using a TCF/Lef reporter gene assay, our data indicate that a
subset of the En1 population responds to Wnt signalling at the
time of dermal specification. Finally, by both loss- and gain-of-
function approaches, we show that the decision to form dermis
instead of muscle and brown fat is critically controlled by β-
catenin through the specification of the dorsal dermal
progenitors.
Results
Central dermomyotome contributes to brown fat, dermis, and
muscle
The fate of cells that express En1 in the mouse central
dermomyotome was determined with an allele of En1 with Cre
recombinase coding sequences inserted (En1Cre) (Hanks et al.,
1995) and the Rosa-floxed Stop-LacZ Reporter allele (RR)
(Soriano, 1999). With these alleles, cells which express En1 and
their progeny are marked by β-galactosidase expression (Zinyk
et al., 1998). E17.5 fetuses carrying single copies of the En1Cre
and RR alleles were sectioned and stained for β-galactosidase
expression (Fig. 1A). In the skin, β-galactosidase expression
was seen in the dermis but not the epidermis. Unexpectedly, all
trunk dermis of the E17.5 fetus at the forelimb level was marked
(Fig. 1A, and data not shown). Some back muscles and bundles
of interscapular brown fat were labeled as well. The brown fat
bundles in the most medial interscapular bundles and in the
axillary depots were not labeled (not shown). The marking of
Fig. 1. The En1-expressing cells of the central dermomyotome contribute to epaxial muscle, dermis, and interscapular brown fat. (A) En1 lineage-marked cells (blue)
are found in the dermis (der), interscapular brown fat (bf), and epaxial muscle (m) of E17.5 day En1Cre/+, RR/+ embryos at the forelimb level. (B and C) At E9.5, En1
is restricted to a few cells of the central dermomyotome. (B) In E9.5, En1LacZ/+ whole-mount embryos expression is only detectable in the ventral ectoderm of the fore
limb bud (FL). (C) In sectioned E9.5 En1LacZ/+ embryos, stained cells are present in the central dermomyotome (inset). (D) En1Cre-ER/+, RR/+ embryos were
treated with tamoxifen in utero at E8.5 and harvested at E16.5. The only labeled trunk mesodermal cells were in the interscapular brown fat (bf). (E) In whole-mount
E10.5 En1LacZ embryos, expression is visible in cervical and thoracic somites. (F) In E10.5 embryo sections, the expression of En1LacZ (blue stain) is in cells of the
somite just underneath the surface ectoderm, as well as in slightly deeper mesenchymal cells (boxed and inset). (G) En1Cre-ER/+, RR/+ embryos were treated on E9.5
with tamoxifen and were examined on E12.5. Stained cells are present in the somite mesenchyme subjacent to the surface ectoderm (arrows) and in deeper cells. (H)
En1Cre-ER/+, RR/+ embryos treated on E9.5 with tamoxifen and harvested on E16.5 have labeled cells in the dermis (boxed and inset), epaxial muscle (arrows), and
brown fat. (I) On E11.5, whole-mount-stained embryos show that En1LacZ is expressed in somites along most of the anterior–posterior axis, and in the ventral
ectoderm and ventral body wall. (J) In the sections, it can be seen that the expression of En1LacZ on E11.5 is present in cells subjacent to the ectoderm (box and inset)
and in deeper cells within the somite. (K and L) En1Cre-ER/+, RR/+ embryos treated with tamoxifen on E10.5 results in labeled cells in the dermal precursors and
deeper cells at E12.5 and in muscle, brown fat, and dermis at E16.5.
166 R. Atit et al. / Developmental Biology 296 (2006) 164–176dermis was more widespread and it is different from what has
been observed in the fate maps of the chick central
dermomyotome (Mauger, 1972; Nowicki et al., 2003; Scaal
and Christ, 2004), suggesting that En1 is expressed in dermal
precursors or mature dermis. As shown below, En1 is
transiently expressed in many dermal progenitors at later
stages. Thus, in order to map the fate of the central
dermomyotome, labeling of cells was limited to short temporal
windows at early stages with an En1 Cre-Estrogen Receptor
(ER) fusion knockin (Sgaier et al., 2005). The Cre-ER fusionprotein is active only when tamoxifen is experimentally
administered, and it is active for about 24 h, starting about 6
h after dosing (Sgaier et al., 2005).
En1 expression in the E9.5 central dermomyotome (David-
son et al., 1988; Davis et al., 1991) is recapitulated by an allele
with β-galactosidase coding sequences knocked into the En1
locus (En1LacZ) (Hanks et al., 1995) (Figs. 1B and C). The
mouse dermomyotome, and particularly the central dermomyo-
tome, does not show a robust epithelial organization like the
chick dermomyotome, so the assignment of labeled cells to the
167R. Atit et al. / Developmental Biology 296 (2006) 164–176dermomyotome layer is based on their position and according to
the stage of the embryo. To lineage-mark the En1 cells of the
E9.5 central dermomyotome, we administered tamoxifen to
pregnant females carrying En1Cre-ER/+, RR/+ embryos at 8.5
days of gestation. β-galactosidase-labeled cells were seen in the
interscapular brown fat of E16.5 fetuses at the level of the
forelimb after E8.5 tamoxifen administration (Fig. 1D). These
results demonstrate that En1-expressing cells of the central
dermomyotome contribute to interscapular brown fat. However,
it was surprising that no dermis or muscle were lineage-marked
in these early labeling experiments.
Dermis and epaxial muscle were marked in addition to
brown fat when tamoxifen was administered 24 h or more later
in development. At E10.5, the En1LacZ allele is expressed in a
narrow domain of the mesenchyme of the central dermomyo-
tome directly underneath the surface ectoderm and in adjacent,
contiguous mesenchymal cells lying slightly deeper within the
somite (Figs. 1E and F). Tamoxifen administered on E9.5-
labeled cells deep back muscles and deep mesenchymal cells,
and presumed dermal precursors on E12.5 (Fig. 1G). At E16.5,
labeled descendents were detected mostly in interscapular
brown fat, with labeled cells in nearby back muscles and in the
dorsal dermis (Fig. 1H). Staining in the dorsal dermis was
restricted to cells in the vicinity of the original En1 expression in
the dermomyotome.
At E11.5, En1LacZ is expressed in a narrow domain of cells
underneath the surface ectoderm, and in a contiguous strip of
mesenchymal cells deeper within the somite (Figs. 1I and J).
Labeled progeny from tamoxifen administered on E10.5 were
present both superficially and deeper at E12.5 (Fig. 1K), and
labeled cells were present in brown fat, muscle, and dermis at
E16.5 (Fig. 1L). In this instance, labeled dermal cells were
distributed above the En1 domain as well as in the midline over
the neural tube. The lateral limit of labeled dermal cells was the
medial third of the scapula at E16.5 (Fig. 1L).
Taken together, our results indicate that cells which express
En1 in the central dermomyotome on E9.5 give rise to
interscapular brown fat. The cells that express En1 on E10.5
give rise to dermis and epaxial muscle, in addition to brown fat,
and these tissues are narrowly distributed. Cells which express
En1 on E11.5 give rise to the same derivatives but, in addition,
also give rise to dermis over the fetal midline. Together, dermal
cells derived from the En1-expressing cells from E9.5 to E11.5
contribute to the dorsal dermis from the fetal midline to the
medial third of the scapula.
En1 expression precedes Dermo1 in some regions but not
others
The timing of expression of En1 and Dermo1, a marker of
dermal specification (Houzelstein et al., 2000; Li et al., 1995),
was compared. In the mouse, Dermo1 is not expressed in the
dermomyotome on E9.5 and E10.5 (Li et al., 1995, and data not
shown) when En1 is expressed in the central dermomyotome
(Figs. 1B, C, E, and F). On E11.5, cells expressing En1LacZ or
lineage-marked by En1Cre are confined to a small medial–
lateral domain (Figs. 2A and B), whereas Dermo1 is expressedin subectodermal mesenchyme in mouse dermal progenitors
with a gap over the neural tube (Fig. 2C). Thus, in the mouse
central dermomyotome, En1 precedes Dermo1 by as much as
48 h.
By E12.5, En1LacZ expression and lineage-labeled cells are
present in the dorsal subectodermal mesenchyme over the
midline and lateral to the central dermomyotome (Figs. 2D and
E). The expression of Dermo1 on E12.5 is similar to that on
E11.5, with no detectable expression over the neural tube (Fig.
2F). Thus, lateral to the central dermomyotome, Dermo1
expression precedes En1 expression by as much as 24 h.
By E14.5, En1LacZ expression is reduced from the levels
seen earlier (Fig. 2G), but lineage-marked dermis, muscle, and
brown fat are evident in En1Cre, RR fetuses (Fig. 2H). On
E14.5, Dermo1 RNA is detectable for the first time in the
mesenchyme over the neural tube (Fig. 2I). Thus, in the
mesenchyme over the midline, En1 expression precedes
detectable Dermo1 expression by at least 24 h.
On E16.5, En1LacZ expression was not detected in the
dorsal mesodermal tissues of the fetus (Fig. 2J), but lineage-
marked cells in En1Cre/+, RR/+ fetuses were present in dermis,
muscle, and brown fat bundles (Fig. 2K). Dermo1 is no longer
expressed in the dermis on E16.5 (not shown).
Thus, En1 expression precedes Dermo1 expression by 48
h in most of the cells, which give rise to the dermis from the
midline to the medial third of the scapula (Fig. 2L). In the flank,
Dermo1 expression precedes En1 expression by about 24
h (Fig. 2L).
Canonical Wnt signal transduction is active prior to and
coincident with Dermo1 expression
At E10.5, the TCF/Lef-lacZ Wnt reporter transgene is
expressed in subectodermal mesenchyme, overlapping
En1LacZ expression there (Figs. 3A and C). By E11.5, the
TCF/Lef-lacZ transgene is expressed throughout much of the
dorsal subectodermal mesenchyme (Fig. 3D), similar to
Dermo1. To test if TCF/Lef-LacZ expression is dependent on
β-catenin, we removed or stabilized β-catenin using conditional
loss-of-function and gain-of-function alleles (Brault et al., 2001;
Harada et al., 1999). TCF/Lef-LacZ expression was lost in β-
catenin loss-of-function mutant En1 cells (Fig. 3E) and was
ectopically expressed in mutant cells carrying the β-catenin
gain-of-function allele, including mutant En1 cells at a distance
from the surface ectoderm (Fig. 3F). Thus, transcription
activated by canonical Wnt signal transduction is active in
subectodermal mesenchyme consistent with a role for Wnt
signaling in dermal specification.
β-Catenin activity is necessary and sufficient for dermal
specification
To determine if dermal specification requires Wnt signal
transduction, we mutated β-catenin in the En1-expressing cells
of the somite. In E11.5 β-catenin conditional loss-of-function
mutant embryos, the domain of Dermo1 expression in the
subectodermal mesenchyme was interrupted: Dermo1
Fig. 2. En1 expression precedes Dermo1 expression medially, but not laterally. (A–C) In E11.5 embryos, Dermo1 is expressed in En1LacZ-expressing and En1Cre-
lineage-marked dermal progenitors in the En1 domain, as well as lateral to the En1 domain. (D–F) In E12.5 embryos, En1LacZ-expressing cells and En1Cre-lineage-
marked cells (arrows and inset in panel D) are detected over the midline neural tube, but Dermo1 expression is not. Lateral to the original En1 domain, En1LacZ
expression and En1Cre lineage-marked cells are detectable in the subectodermal mesenchyme. (G–I) By E14.5, Dermo1 expression can be detected over the fetal
midline above the neural tube. (J and K) En1LacZ expression is greatly diminished by E16.5 and is not detectable in the dermis (inset in panel J), whereas En1Cre
lineage-marked cells are prevalent in dermis, brown fat bundles, and muscle (K). (L) Schematic of the fate map of the En1-expressing somite cells. En1 is expressed
(gray shading) in the central dermomyotome at E9.5 in cells fated to become brown fat (bf). These cells displace to the interior and are replaced by medial cells in the
dermomyotome. On E10.5, En1 is expressed in cells directly underneath the surface ectoderm and in deeper cells. Cells that now express En1 are fated to dermis (d)
and muscle (m) in addition to the deeper cells which are fated to brown fat. By E11.5, cells adjacent to the surface ectoderm express Dermo1. By E12.5, some cells of
the En1 domain move dorsomedially underneath the surface ectoderm, and En1 becomes broadly expressed (lighter gray) in the dermal progenitors.
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and E). Dermo1 expression was present lateral to the mutant
cells and was also present at lower levels in a small domain
medial to the mutant cells. Thus, β-catenin is necessary for
Dermo1 expression in the En1 lineage-marked cells of the
somite. To determine if β-catenin is sufficient for Dermo1
expression, we analyzed embryos carrying a gain-of-function
conditional allele of β-catenin. Dermo1 was expressed in all
cells that expressed stabilized β-catenin, including ectopic
expression in mesenchymal cells distant from the surface
ectoderm (Figs. 4C and F). Combined, these results indicate that
β-catenin is necessary and sufficient for dermal specification as
assayed by expression of Dermo1.
To determine if proliferation or programmed cell death was
altered when β-catenin was mutated, we determined DNA
synthesis and apoptosis on E10.5. Both the β-catenin loss-of-
function and gain-of-function mutant cells had lower levels of
BrdU incorporation (Figs. 5A–C and Table 1), but the
differences in BrdU labeling did not reach statisticalsignificance (P > 0.05), nor did the results reach statistical
significance when they were partitioned into deep cells and
cells within three cell diameters of the surface ectoderm (Table
1). Very few apoptotic cells were detected by TUNEL staining
in wild-type embryo sections in the En1 domain, and there
were no detectable changes in TUNEL labeling in the mutant
cells (Figs. 5D–F). Thus, any changes in proliferation were
either too subtle to detect or occurred earlier in development
than assayed.
Expression of myogenin is altered in β-catenin mutant cells
To determine whether the specification of muscle
progenitors was altered in the β-catenin mutants, we assayed
muscle specification by staining for the bHLH myogenic
transcription factor myogenin (Sassoon et al., 1989; Smith et
al., 1994). At E11.5, cells lineage-marked by the En1Cre
allele are contiguous with each other, not mixing with
unlabeled cells except at the edges of the domain. When
Fig. 3. AWnt reporter transgene is expressed in the subectodermal mesenchyme. (A and B) En1LacZ expression in the somite at E10.5 and E11.5. (C) At E10.5, the
TCF/Lef-LacZ transgene is expressed in subectodermal mesenchyme in the same region as En1 is expressed. (D) On E11.5, the TCF/Lef-LacZ transgene is expressed
throughout the subectodermal mesenchyme. (E) In E11.5 embryos with β-catenin tissue-specifically mutated in En1-expressing cells, there is a gap in the TCF/Lef-
LacZ transgene expression in the En1 domain. (F) E11.5 embryos with β-catenin stabilized in En1-expressing cells show ectopic expression of the TCF/Lef-LacZ
transgene.
169R. Atit et al. / Developmental Biology 296 (2006) 164–176E11.5 embryos were sectioned and stained with antibodies
for β-galactosidase from the RR allele and for myogenin, it
was not always possible to identify positively double-labeled
cells because the antibody to β-galactosidase stains puncta
in the cytoplasm and the antibody to myogenin stains
nuclei. However, because lineage-labeled cells do not mix
with unlabeled cells, myogenin-positive nuclei within the
En1 domain were considered as En1 lineage-marked cells,
which also expressed myogenin. In wild-type lineage-marked
embryos, myogenin-positive cells are present in the deeper
parts of the En1 domain, but not in the subectodermal
mesenchyme (Figs. 6A–C). In β-catenin conditional loss-of-
function mutant embryos, there was an increase in the
number of lineage-labeled cells, which expressed myogenin,
particularly in the subectodermal mesenchyme (Figs. 6D–F).
In β-catenin gain-of-function mutant embryos, there was a
dramatic reduction in the number of lineage-labeled cells
that expressed myogenin (Figs. 6G–I). Taken together, these
results demonstrate that there is increased specification of
muscle progenitor cells in the β-catenin loss-of-function
mutants and decreased specification of muscle progenitors
upon stabilization of β-catenin.Dorsal dermis is absent in β-catenin mutants
Hair follicles develop from the epidermis but their formation
depends on interactions with dermis (Schmidt-Ullrich and Paus,
2005). Thus, for an overview of the distribution of functional
dermis, 14.5 day fetuses were probed for Ptch1 mRNA by
whole-mount in situ hybridization to mark hair placodes (Oro et
al., 1997). Ptch1-positive hair placodes were absent on the
dorsum of mutant embryos but had a normal density and
appearance on the flanks (Figs. 7A–D) despite the fact that all
dermis is lineage-marked and mutant for β-catenin (Fig. 8E and
data not shown). Embryos mutant for the β-catenin conditional
gain-of-function allele died between E12 and E13 so the effect
of activation of β-catenin could not be analyzed at these later
stages.
Histological analysis of E16.5 mutant fetuses showed that
dense, compact mesenchyme characteristic of dermis was
absent in the dorsum (Figs. 7F and 8F) and the brown fat
abutted the epidermis (Fig. 8F). Laterally, on the flanks of
the mutant embryos, dermis and hair placodes were present
and appeared normal in section (Figs. 7G and H). β-Catenin
is eliminated in En1-expressing cells of the ventral limb
Fig. 4. Dermo1 expression is dependant on β-catenin. Paired adjacent sections of E11.5 embryos were analyzed for Dermo1 expression and En1 lineage-marked cells.
(A and D) Dermo1 is expressed in the subectodermal mesenchyme in En1Cre/+, RR/+ embryos. (B and E) Dermo1 expression is not detectable in β-catenin loss-of-
function mutant cells. (C and F) Dermo1 is ectopically expressed in the presence of activated β-catenin.
170 R. Atit et al. / Developmental Biology 296 (2006) 164–176ectoderm (Davis et al., 1991), which also results in loss of
hair follicle development in the ventral limb (data not
shown).
In E12.5loss-of-function mutants, the surface of the embryo
typically showed an indentation at the location of the En1
domain (Fig. 8A), and Dermo1 expression persisted medial and
lateral to the domain of mutant cells but was not detected in the
dorsal cells (Fig. 8B). By E14.5, the dorsal subectodermal
mesenchyme was cell-poor (Fig. 8C). In the flank of E14.5
embryos, Dermo1 was expressed (Fig. 8D) and there was
normal appearing compact dermis (Fig. 8E) consistent with the
subsequent formation of hair placodes. We interpret the
formation of flank dermis in the mutants as due to later
mutation of β-catenin in these cells, after dermal specification
has occurred.
Taken together, our results demonstrate the importance of
Wnt signal transduction in the specification and formation of theFig. 5. No change in proliferation or cell death in β-catenin mutant cells. (A–C) There
catenin loss-of-function and gain-of-function cells (see Table 1 for quantitation). The
as measured by TUNEL staining is not changed in the mutant cells.dorsal dermis from the En1 domain of the central
dermomyotome.
Discussion
In this work, we aimed to identify the signal required for the
specification of the dermal lineage from the mouse dermomyo-
tome. We conclusively show with genetic techniques that Wnt
signal transduction in the central dermomyotome is required for
dorsal dermis specification and development in the mouse
embryo. Studies in the chick embryo have demonstrated the role
of Wnt1 in survival of dorsal dermal progenitors and later in
skin patterning. Using multiple genetic fate mapping techniques
and conditional β-catenin mutants, we systematically demon-
strate an earlier role of Wnt signaling in selecting dermal fate
from a tripotential tissue expressing En1 in the central
dermomyotome of the mouse.is no change in the number of cells that incorporate BrdU (brown stain) in the β-
domain of En1 lineage-marked cells is outlined with a red line. (D–F) Apoptosis
Table 1
Proliferation in β-catenin mutant cells
β-Catenin
genotype
Number of
embryos analyzed
En1 domain En1 domain three cells subjacent to ectoderm
BrdU-positive cells (%) SD P BrdU-positive cells (%) SD P
Wild type 5 60.2 8.4 66.3 8.9
Loss of function 4 46.4 5.1 0.098 54.9 15.9 0.52
Gain of function 4 46.8 4.8 0.082 53.9 10.9 0.78
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dermomyotome
The genetic fate mapping of En1-expressing cells identifies
the En1 central dermomyotome as a major source of
interscapular brown fat. At E9.5, En1 is expressed in the
central dermomyotome of the somites at cervical and forelimb
levels and these cells contributed only to the interscapular
brown fat. This restriction was surprising, and at later stages
En1 lineage-marked cells generated descendants in the dermis
and epaxial muscles as expected, in addition to interscapular
brown fat. On E11.5, En1-expressing cells gave rise to dermis
over the fetal midline, whereas at earlier stages the dermalFig. 6. Myogenin expression is altered in β-catenin mutants. Sections of E11.5 embr
mutant cells. In wild-type embryos (A–C), myogenin is expressed in deep cells of
ectopic myogenin-positive cells are found close to the surface ectoderm. In β-catenin
domain.progeny were limited to about the extent of the original En1
domain. There are two novel outcomes of these experiments:
firstly, that the fate of En1 cells changes in time with an increase
in the diversity of cell types made, and secondly, that some
interscapular brown fat bundles have their origin in the En1-
expressing cells of the central dermomyotome.
The change in fate of En1 cells from brown fat at an early
stage to brown fat, dermis, and muscle at later stages in the
tamoxifen experiments is unexpected. It is possible but unlikely
that the fate restriction to fat at early stages might be apparent
rather than real, reflecting the fact that brown fat is the major cell
type labeled in all of the tamoxifen induction experiments and
other fates were adopted but were missed in the early inductions.yos were stained with antibodies to myogenin and to β-galactosidase to identify
the lineage-marked domain. In β-catenin loss-of-function mutant cells (D–F),
gain-of-function mutants (G–I), myogenin-positive cells are absent from the En1
Fig. 7. Dorsal hair placodes and dermis are absent in β-catenin loss-of-function
mutants. (A–D) Hair placodes identified with a Ptch1 probe are absent on the
dorsum of mutant embryos but are present on the flanks. (E and F) Histological
dermis and hair follicles are absent in the dorsal skin of the mutant fetuses. (G
and H) Dermis and hair follicles are present in the flank of E16.5 mutant fetuses
(fl, forelimb; hf, hair follicle; bf, brown fat; arrows, hair follicles).
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a real change in fate. An increase in the number of cell types
made by En1 cells at later stages would require that early En1
cells be replaced by new cells that turned on En1 and contributed
to all three fates. Cells have been shown to move laterally within
the dermomyotome from the DML and turn on En1 in the chick
embryo (Cheng et al., 2004; Ordahl et al., 2001). It may be that a
similar process is at work in the mouse, with early En1-
expressing cells of the central dermomyotome moving deep
away from the surface, becoming incorporated into brown fat,
replaced by medial cells which turn on En1 and have the
potential, at least collectively, to form all three cell types.
Continued translocation of DML cells into the En1 domain at
later stages could also explain why early inductions did not
detect progeny in midline dermis, but tamoxifen administration
on E10.5 did give rise to labeled cells in midline dermis.
Our fate mapping results identify the origin of some of the
interscapular bundles of brown fat in the En1-expressing cells
of the central dermomyotome. Brown fat is a thermogenic orheat-producing tissue found only in eutherian mammals
(Cannon and Nedergaard, 2004; Nicol et al., 1997; Rothwell
and Stock, 1985). The interscapular bundles are the major
depots of brown fat in the mouse, and their embryological
origin was not known previously. Not all interscapular brown
fat bundles were labeled by En1 lineage marking—the more
medial interscapular brown fat bundles were not lineage-
labeled by En1Cre nor were axillary brown fat bundles (data
not shown). It seems reasonable that the more medial bundles
of brown fat derive from dermomyotome medial to the En1
domain, possibly the Wnt11-expressing cells of the dermo-
myotome, although this possibility was not examined directly.
Other small contributions to interscapular brown fat are not
excluded by these experiments – for example, some
undetected population which also expresses En1 – but the
fact that the marked brown fat bundles are surrounded by
marked muscle and connective tissue and the extensive
labeling of brown fat in the tamoxifen induction experiments
make it unlikely.
Although there is little known about the early development
of brown fat, there is one mutant which supports our finding that
brown fat shares a developmental origin with muscle. Mice
mutant for the myogenic transcription factor myogenin have a
deficit of epaxial muscle and an excess of brown fat bundles in
the cervical and interscapular region (Hasty et al., 1993).
Similarly, fetuses mutant for both Myf5 and MyoD have an
excess of bundles of fat cells in the place of some epaxial
muscles (Kablar et al., 2003), although it was not said if this
ectopic fat is brown or white. An alternative explanation for the
excess of fat in mutants lacking muscles is that the adipocytes
are released from inhibitions on its growth rather than arising
from a change in specification. Nonetheless, considered
together with our current experiments, we conclude that in the
mouse, the central dermomyotome is a tripotent tissue.
Fate maps of dorsal dermis in the mouse
In the chick, the fate of different parts of the somite and
dermomyotome with respect to the dorsal dermis has not been
resolved with agreement on all details, in particular, the origin
of the dermis over the midline (Scaal and Christ, 2004). Our
work in mouse may be different from chick but it conclusively
shows the origin of the midline dermis in the mouse. The results
obtained by temporally restricted activation of Cre recombinase
to 24-h windows show that the central dermomyotome
generates dermis and that it contributes to dermis over the
fetal midline. The extent of contribution cannot be determined
quantitatively from the data due to the low activity of the Cre-
ER fusion protein, but the results from the mutant phenotype
suggest that the contribution is substantial. In the β-catenin
conditional loss-of-function mutants, Dermo1 expression is lost
in the En1 domain, but toward the midline from the En1 domain
there is a small group of cells that continue to express Dermo1.
This group of cells is likely composed of Wnt11-expressing
cells medial to the En1 domain in the dermomyotome. In the β-
catenin conditional mutants, this small group of cells is not
sufficient to rescue later midline Dermo1 expression, the
Fig. 8. Development of dermis is disrupted in En1Cre β-catenin loss-of-function mutant cells dorsally, but not in the flank. (A) In E12.5 embryos, En1 lineage-marked
cells are absent from the subectodermal mesenchyme and there is an indentation in the surface of the embryo over the En1 domain. (B) At E12.5, the expression of
Dermo1 is not detectable in mutant cells. (C) At E14.5, β-catenin loss-of-function cells are present in a loose, cell-poor mesenchyme under the dorsal surface ectoderm.
(E) Laterally on E14.5, lineage-labeled β-catenin loss-of-function cells organize into a typical appearing dense dermis (der). (F) By E16.5, dorsal dermis is absent and
brown fat (bf) bundles are immediately adjacent to the surface ectoderm.
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placodes. These results suggest that some cells medial to the
En1 domain do contribute to the midline dermis, but that their
contribution is minor.
Our fate mapping results and the analysis of the mutants
taken together suggest that there is little lateral dispersion of
En1 cells from the central dermomyotome in the dermal layer,
with the lateral limit probably corresponding to the lateral
boundary of the early expression of En1 in the dermomyotome
and the medial third of the scapula at later stages. Our results in
the mouse and the results of others in the chick (Ben-Yair et al.,
2003) do not appear to be consistent with a substantial early and
direct contribution of DML cells to the midline dermis as
suggested for the mouse (Houzelstein et al., 2000) and chick
(Olivera-Martinez et al., 2002). However, as argued above, they
are consistent with translocation of DML cells into the central
dermomyotome where they turn on En1 (Cheng et al., 2004)
and then give rise to dermis, including the midline dermis later
in development.
The formation of dermis and induction of hair follicle in the
flank of the mutant mice occurs despite the fact that the dermis
in this region of the fetus is lineage-marked and mutant for β-
catenin. We suggest that the difference between flank and dorsal
dermal phenotypes is due to the different timing of β-catenin
loss in these two tissues. En1 is expressed in the flank dermisafter Dermo1 expression, and thus presumably after specifica-
tion of dermal progenitors. Thus, in the β-catenin conditional
loss-of-function mutants where excision is driven by Cre
expressed from the En1 locus, loss of β-catenin should occur
after dermal specification in the flank. β-catenin is required
within the other layer of the skin, the epidermis, for placodes to
form (Huelsken et al., 2001). Within the dermis, transient β-
catenin expression and β-catenin-directed transcriptional activ-
ity have been observed in the dermal condensations preceding
hair follicle formation, and it has been suggested that dermal β-
catenin might be necessary for hair development (DasGupta and
Fuchs, 1999). However, the present results show that β-catenin
is not required in the dermis after dermal progenitor
specification, at least for development of hair placodes in the
flank up to stage E17.5.
When β-catenin is activated in the somite, all mutant cells
express Dermo1, suggesting that the cells are respecified to the
dermal progenitor fate. A comparable marker for brown fat
progenitors is not available, but all or most cells with activated
β-catenin fail to express myogenin. Unless the Dermo1-positive
cells in the β-catenin gain-of-function experiment also are
simultaneously specified to brown fat, it seems likely that
activation of Wnt signal transduction has inhibited brown fat
specification. With loss of β-catenin, Dermo1 expression is lost
in the somite, and there is an apparent increase in myogenin-
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where dermal progenitors are normally found. It is not clear if
the myogenin-positive cells were respecified to the myogenic
fate, or whether they are normally specified cells that are
abnormally displaced to the subectodermal mesenchyme due to
the absence of dermis. However, the fact that there are no
significant differences in the proliferation of the mutant cells
and no detectable cell death, it seems likely that these cells have
been respecified. Respecification of somite cells has been
observed previously in mutant embryos, where cells that were in
the myogenic lineage instead adopt dermal and skeletal fates in
the absence of Myf5 (Tajbakhsh et al., 1996). Contradictory to
our report, Wnt signaling has been shown to promote
myogenesis. Our report on myogenin expression in β-catenin
mutants suggests an inhibitory role of Wnt signaling in adopting
myogenic fate. Taken together, our results are consistent
because Dermo1 expression complement myogenin expression
in the gain- and loss-of-function for β-catenin mutants. The
inhibitory role of Wnt signaling in myogenic fate may be due to
a specific population of cells from the En1 lineage-marked cells
in the central dermomyotome.
Instructive role for β-catenin in dorsal dermis specification
Together, the lineage mapping results and the outcomes with
loss-of-function and gain-of-function roles point to an instruc-
tive role for β-catenin and canonical Wnt signaling in dermal
specification. En1-expressing cells of the somite were fate
mapped to dermis, muscle, and interscapular brown fat,
demonstrating that the central dermomyotome tissue is tripotent
in the mouse. The changes in expression of the dermal and
muscle progenitor markers with manipulation of β-catenin
suggest that Wnt signaling is necessary and sufficient for cells
to express Dermo1 and adopt the dermal progenitor fate. The
absence of changes in cell death or DNA synthesis suggests that
if Wnt signal transduction alters survival or growth, the effect is
minor. The complementary changes in myogenic fates support
the idea that the role of Wnt signalling is instructive. The
temporal requirement for β-catenin at the time of dermal
specification, and not for subsequent differentiation and
survival, shows that the role of Wnt signaling is limited to the
window around specification. The pattern of expression of the
reporter gene for β-catenin transcriptional activity in normal
embryos suggests that cells underneath the surface ectoderm
convert Wnt signals into transcriptional activity. This transcrip-
tional activation is present only in En1 lineage cells close to the
surface ectoderm, those which express Dermo1 and presumably
later form dermis and not the deeper cells that become muscle
and brown fat. This pattern of Wnt signal transduction and
specification is most consistent with a Wnt signal produced
locally from the surface ectoderm. The surface ectoderm is the
site of expression of multiple Wnt genes in the mouse and at
least one Wnt in the chick (Parr et al., 1993; Rodriguez-
Niedenfuhr et al., 2003; Schubert et al., 2002; Tajbakhsh et al.,
1998). Deeper cells derived from the En1 domain might adopt
brown fat and muscle fates due to attenuated Wnt signals, or due
to the predominance of other signals. Our results do not suggestwhat mechanism selects between the muscle and brown fat fates
but do indicate that Wnt signalling is inhibitory for the adoption
of these fates. From these results, we propose that Wnt signals
from the surface ectoderm are transduced by central dermo-
myotome cells close the surface ectoderm, and that this instructs
cells to select the dermal progenitor fate from the three fates
available to them.
How transduction of Wnt signals causes central dermomyo-
tome cells to select the dermal fate is not clear. Although Wnt
signals induce and maintain En1 expression in the somite
(Cheng et al., 2004; Ikeya and Takada, 1998; Olivera-Martinez
et al., 2002) (our unpublished results), En1 is not necessary for
the development of dermis, muscle, or brown fat (data not
shown). The identification of the genes that respond to β-
catenin activation and select the dermal fate is the next step in
understanding dermal specification.
Methods
Mice
En1Cre (Kimmel et al., 2000), En1LacZ (Loomis et al., 1998), En1Cre-ER
(Sgaier et al., 2005), Rosa-floxed Stop-LacZ Reporter (Soriano, 1999), TCF/
Lef-LacZ reporter (Liu et al., 2003), β-catenin conditional loss-of-function
(Brault et al., 2001), and β-catenin conditional gain-of-function (Harada et al.,
1999) mice and embryos were genotyped as described. Tamoxifen was
administered by gavage to pregnant females as described (Sgaier et al., 2005).
Three to seven embryos from 2 to 3 different litters were analyzed. Pregnant
mice were injected intraperitoneally with 100 mg/kg BrdU (Sigma).
In situ hybridization, immunocytochemistry, histochemistry, and
histology
Embryos were fixed for 30 min to 1 h in 4% paraformaldehyde in PBS,
washed in PBS, and equilibrated in a graded series of solutions up to 25%
sucrose and embedded in OCT (Tissue-Tek). Frozen sections at the forelimb
level were processed for in situ hybridization (Holmes and Niswander, 2001).
For whole-mount in situ hybridization, E14.5 embryos were fixed in 4%
paraformaldehyde in PBS overnight and then processed as described
(Henrique et al., 1995), except that the protease treatment was 7.5 μg/ml
proteinase K for 15 min at room temperature and the color reaction was
developed with BM Purple (Roche). The mouse Dermo1 probe was a gift from
Eric Olson and the Ptch1 plasmid was a gift from Matt Scott. For
immunocytochemistry, frozen sections were treated as described (Yamada et
al., 1993). Antibodies used were against rat myogenin (monoclonal, 1:1.5;
Developmental Studies Hybridoma Bank, IA), β-galactosidase (goat, 1:500,;
Biogenesis), BrdU (monoclonal, 1:8; Roche), as well as appropriate secondary
antibodies conjugated to FITC or Cy3 (1:250; Jackson Immunoresearch).
Histochemical staining for β-galactosidase expression from reporter transgenes
was performed on frozen sections of embryos processed as described (Rivera-
Perez et al., 1999). For histology, E16.5 embryos were fixed for 8 h in 4%
paraformaldehyde in PBS, embedded in paraffin, sectioned, and stained with
hematoxylin and eosin.
Cell proliferation and apoptosis
Two hours after BrdU injection, embryos were harvested, fixed for 1 h in 4%
paraformaldehyde in PBS, and processed for frozen sections as described above.
Sections were treated with 1 M HCl at 50°C for 2 min, washed, and stained with
mouse anti-BrdU (2 μg/ml, Roche) followed by biotinylated secondary antibody
(1:250 Vector), amplified using the reagents of an ABC kit (Vectastain), and
visualized by 3,3′-diaminobenzidine staining and counterstaining with hema-
toxylin. Apoptotic cell death was assayed by TUNEL using TMR Red (Roche)
according to the kit's instructions.
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